| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Cancer Institute (NCI) |
| Information provided by: | National Cancer Institute (NCI) |
| ClinicalTrials.gov Identifier: | NCT00427726 |
Purpose
RATIONALE: Studying the long-term effects of gene therapy in patients with breast cancer or multiple myeloma over time may help doctors plan better treatment and follow-up.
PURPOSE: This natural history study is collecting health information from patients with breast cancer or multiple myeloma previously treated on a gene therapy clinical trial.
| Condition | Intervention |
|
Breast Cancer Multiple Myeloma and Plasma Cell Neoplasm |
Procedure: laboratory biomarker analysis Procedure: molecular genetic technique |
| Genetics Home Reference related topics: | aceruloplasminemia breast cancer hemophilia |
| MedlinePlus related topics: | Breast Cancer Cancer Multiple Myeloma |
| Study Type: | Observational |
| Official Title: | Follow-Up Study Of Breast Cancer And Multiple Myeloma Subjects Previously Enrolled In Retroviral Gene Transfer Studies |
| Estimated Enrollment: | 13 |
| Study Start Date: | March 2003 |
OBJECTIVES:
OUTLINE: Patients are contacted to update health status and collect blood samples every 6 months for 5 years and then annually for at least 10 years. Blood samples are tested for presence of retroviral gene transfer vector and replication competent retrovirus.
PROJECTED ACCRUAL: A total of 13 patients will be accrued for this study.
Eligibility
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Received gene transfer products while enrolled in 1 of the following clinical trials for the treatment of breast cancer or multiple myeloma:
Hormone receptor status:
PATIENT CHARACTERISTICS:
Age
Sex
Menopausal status
Performance status
Life expectancy
Hematopoietic
Hepatic
Renal
PRIOR CONCURRENT THERAPY:
Biologic therapy
Chemotherapy
Endocrine therapy
Radiotherapy
Surgery
Other
Contacts and Locations More Information
Clinical trial summary from the National Cancer Institute's PDQ® database
|
| Study ID Numbers: | CDR0000299050, NCI-03-C-0124 |
| First Received: | January 25, 2007 |
| Last Updated: | July 23, 2008 |
| ClinicalTrials.gov Identifier: | NCT00427726 |
| Health Authority: | United States: Federal Government |
|
|
|
|
|
|
